From Medscape HIV/AIDS

Coverage from the

International AIDS Conference 2016

July 18 - 22, 2016; Durban, South Africa

July 18 - 22, 2016 Durban, South Africa

AIDS Long-Acting Injectable Antiretroviral Safe, Effective The first long-acting injectable antiretroviral regimen is safe and effective at 48 weeks, and patients find it very convenient, new research suggests.
Medscape Medical News, July 25, 2016
AIDS HIV Vaccine Trial Gets Green Light Immune responses to candidate HIV vaccines in a South African population were so robust that a large phase 2b/3 efficacy trial will be launched.
Medscape Medical News, July 22, 2016
AIDS Latest HIV Cure Data Expose Resilience of Infection Disappointing results from SEARCH 19 and other recent studies are a challenge for researchers, who must balance progress with the fact that most patients are doing well on antiretroviral therapy.
Medscape Medical News, July 19, 2016

Conference News

AIDS HIV Self-tests Promote Screening Among Men at High Risk
Medscape Medical News, July 26, 2016
AIDS Long-Acting Injectable Antiretroviral Safe, Effective
Medscape Medical News, July 25, 2016
AIDS Once-Daily Dolutegravir Regimen Assists Women With HIV
Medscape Medical News, July 25, 2016
AIDS HIV Vaccine Trial Gets Green Light
Medscape Medical News, July 22, 2016

AIDS Real-World PrEP Use Virtually Eliminates HIV Transmission
Medscape Medical News, July 21, 2016
AIDS Bacterial Vaginosis Raises HIV Risk, Lowers Tenofovir Level
Medscape Medical News, July 19, 2016
AIDS Latest HIV Cure Data Expose Resilience of Infection
Medscape Medical News, July 19, 2016
AIDS Titanic Shift in Attitude Anticipated at AIDS 2016
Medscape Medical News, July 8, 2016

Popular News from AIDS 2015

HIV Cure Advancing From Isolated Cases to Clinical Trials HIV research is evolving from exceptional cases of long-lived remission to early clinical trials in which scientific theories are being put to the test.
Medscape Medical News, Jul 24, 2015
START Antiretrovirals Early, 35-Country Trial Validates Patients treated with antiretrovirals immediately after diagnosis were half as likely to die or develop AIDS or other serious illnesses as those whose therapy was delayed, report investigators.
Medscape Medical News, Jul 20, 2015
Single-Pill Hep C Treatment Effective in Patients With HIV A study in which patients coinfected with hepatitis C and HIV achieved response rates of 96% may erase the bias that HIV patients don't do well on direct-acting antivirals for hepatitis C.
Medscape Medical News, Jul 22, 2015

Medscape HIV/AIDS© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentary

International Aids Conference: Novel Studies Compare ART Regimens
Paul E. Sax, MD

Previous Coverage

Related Resource

HIV Transmission, Prevention News & Perspectives